ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,586 Cr | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,586 Cr |
| Mar2025 | ₹7,709 Cr |
| Mar2024 | ₹6,341 Cr |
| Mar2023 | ₹6,064 Cr |
| Mar2022 | ₹7,230 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,586 Cr | 11.38 | |
| Mar2025 | ₹7,709 Cr | 21.57 | |
| Mar2024 | ₹6,341 Cr | 4.58 | |
| Mar2023 | ₹6,064 Cr | -16.13 | |
| Mar2022 | ₹7,230 Cr | - | |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,012.1 Cr | -2.3% | 5.6% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -2.3% |
5.6% |
-22.8% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses